CJC-1295/Ipamorelin.
Two peptides that signal the pituitary gland to release the body's own growth hormone. Compounded CJC-1295 (no DAC) with ipamorelin may be prescribed if a licensed clinician determines it is appropriate for you.
What to expect.
- Two peptides in one compounded protocol
- Administered by subcutaneous injection on a schedule set by your clinician
- Prescribed only after a medical intake and clinician review
- Check-ins and adjustments through your care team
About CJC-1295/Ipamorelin.
Also known as: CJC-1295 without DAC, Modified GRF (1-29), Ipamorelin acetate
CJC-1295 without DAC (modified GRF 1-29) and ipamorelin are two peptides that signal the pituitary gland to release the body's own growth hormone. They are often prescribed together.
Live Vital prescribes this combination as a compounded preparation made by a licensed pharmacy for an individual patient. It is not FDA-approved and has not been evaluated by the FDA for safety, effectiveness or quality. It is available only after a medical intake and review by a licensed clinician, and only if the clinician determines it is appropriate for you.
How it works
CJC-1295 without DAC binds growth hormone-releasing hormone (GHRH) receptors in the pituitary. Ipamorelin binds the ghrelin receptor on the same cells. Together they prompt a short pulse of growth hormone release. Prescribed doses are administered by subcutaneous injection on a schedule your clinician sets after your intake.
Who may be evaluated.
- Adults interested in a clinician-supervised longevity protocol
- Eligibility is determined by a licensed clinician after a medical intake
How treatment is managed.
Your clinician sets the dose and schedule after your intake and reviews it at regular check-ins. Outcomes vary by individual and are not guaranteed.
Dosing is not one-size-fits-all. Your clinician sets your dose and schedule after your medical intake, and adjusts it as treatment progresses.
Safety information.
Possible side effects
- Water retention
- Tingling or numbness in hands or feet
- Injection site reactions
- Headache
- Flushing
- Transient lightheadedness
- Temporary increase in hunger
Who should talk to us first
- Active malignancy or history of cancer
- Pregnancy or breastfeeding
- Pituitary tumors or disorders
- Diabetic retinopathy
- Uncontrolled diabetes
This information is educational and is not a substitute for medical advice. Every treatment requires a medical intake and review by a licensed clinician, not all patients qualify, and outcomes vary by individual.
Standard with every plan.
Clinician-prescribed
Prescribed by a licensed clinician on Live Vital’s medical team, only if appropriate for you.
Licensed US pharmacy
If prescribed, prepared by a licensed US pharmacy and shipped to you.
Unlimited messaging
Reach our care team directly with questions at any time.
Questions about CJC-1295/Ipamorelin.
Ready to get started?
Complete the intake and a licensed clinician will review whether CJC-1295/Ipamorelin is appropriate for you. Not all patients qualify.
Compounded medications are prepared by a licensed pharmacy for an individual patient. They are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness or quality. Prescription treatments require an evaluation by a licensed clinician. Not all patients qualify. Outcomes vary by individual and are not guaranteed. Refund and cancellation policy.